Skip to main content
. 2021 Oct 21;138(16):1465–1480. doi: 10.1182/blood.2020009871

Figure 3.

Figure 3.

Maturation of NK cells into cytotoxic effectors is perturbed in PBMCs from patients with B/T-ALL. Flow cytometry analysis of NK cells showing the percentages of CD94, CD56brightCD94+, CD56dimCD94High, and CD56dimCD94Low NK cells (A-B), KIR2DL1+ total NK cells and CD56brightKIR2DL1+ and CD56dimKIR2DL1+ NK cells (C-D), CD11bCD27, CD11bCD27+, CD11b+CD27+, and CD11b+CD27 NK cells (E-F) in PBMCs from healthy donors (n = 9) and B/T-ALL patients (n = 9). (G-H) Flow cytometry analysis of NK cells showing the percentages of DNAM-1+ total NK cells and CD56brightDNAM-1+, CD56dimDNAM-1+, and CD56dimDNAM-1NK cells in PBMCs from healthy donors (n = 6) and B/T-ALL patients (n = 6). Graphs show median ± interquartile range. Gates for each marker were set using fluorescence − 1 (FMO) controls. Exact P values were calculated using the Mann-Whitney U test. ns, nonsignificant.